VanEck Vectors Pharmaceutical ETF (PPH)
PPH is a passive ETF by VanEck tracking the investment results of the MVIS US Listed Pharmaceutical 25 Index. PPH launched on Dec 20, 2011 and has a 0.36% expense ratio.
ETF Info
US92189F6925
92189F692
Dec 20, 2011
Developed Markets (Broad)
1x
MVIS US Listed Pharmaceutical 25 Index
Multi-Cap
Blend
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in VanEck Vectors Pharmaceutical ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
VanEck Vectors Pharmaceutical ETF had a return of 9.00% year-to-date (YTD) and 14.42% in the last 12 months. Over the past 10 years, VanEck Vectors Pharmaceutical ETF had an annualized return of 4.96%, while the S&P 500 had an annualized return of 11.13%, indicating that VanEck Vectors Pharmaceutical ETF did not perform as well as the benchmark.
PPH
9.00%
-6.61%
-2.86%
14.42%
9.32%
4.96%
^GSPC (Benchmark)
24.05%
1.08%
11.50%
30.38%
13.77%
11.13%
Monthly Returns
The table below presents the monthly returns of PPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.83% | 4.10% | 2.14% | -2.88% | 3.31% | 1.13% | 2.15% | 6.82% | -4.43% | -3.50% | 9.00% | ||
| 2023 | 0.77% | -3.43% | 2.62% | 2.47% | -4.08% | 4.12% | 2.60% | 1.84% | -2.49% | -5.29% | 4.25% | 4.03% | 6.95% |
| 2022 | -1.44% | -0.18% | 5.35% | -2.23% | 2.17% | -3.02% | 0.40% | -8.01% | -4.95% | 8.78% | 5.74% | 1.23% | 2.64% |
| 2021 | 2.51% | -0.90% | 2.21% | 1.24% | 3.78% | 1.26% | 2.87% | 1.58% | -4.23% | 3.69% | -4.95% | 8.12% | 17.79% |
| 2020 | -0.14% | -7.86% | -7.89% | 12.04% | 4.52% | -1.64% | 1.63% | 2.40% | -3.66% | -4.86% | 10.41% | 2.61% | 5.48% |
| 2019 | 6.95% | 3.58% | 0.03% | -3.50% | -5.98% | 7.18% | -1.61% | -1.78% | 0.99% | 4.55% | 4.83% | 3.56% | 19.39% |
| 2018 | 3.68% | -5.95% | -1.73% | 0.48% | 2.40% | 1.64% | 5.38% | 2.76% | 1.15% | -5.73% | 3.72% | -12.28% | -5.87% |
| 2017 | -0.36% | 6.29% | -0.85% | 0.96% | 3.89% | 2.98% | -1.30% | -4.07% | 3.83% | -4.00% | 3.98% | 3.52% | 15.23% |
| 2016 | -7.78% | -4.68% | 0.16% | 2.40% | 1.08% | -0.42% | 6.06% | -4.85% | -2.40% | -9.49% | 0.06% | 1.57% | -17.78% |
| 2015 | 1.68% | 5.89% | 1.50% | 1.45% | 3.11% | -3.02% | 5.27% | -8.30% | -7.44% | 3.50% | -0.25% | 1.23% | 3.53% |
| 2014 | 1.92% | 9.96% | -1.93% | 3.65% | 0.17% | 3.07% | -1.93% | 2.62% | 2.24% | 0.01% | 4.50% | -2.59% | 23.19% |
| 2013 | 7.24% | 0.40% | 5.45% | 3.70% | 0.06% | -1.90% | 5.70% | -2.72% | 2.93% | 4.40% | 4.79% | 2.26% | 36.83% |
Expense Ratio
PPH features an expense ratio of 0.36%, falling within the medium range.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PPH is 43, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
VanEck Vectors Pharmaceutical ETF provided a 1.84% dividend yield over the last twelve months, with an annual payout of $1.61 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.61 | $1.70 | $1.20 | $1.25 | $1.10 | $1.14 | $1.08 | $1.14 | $1.27 | $1.26 | $1.10 | $1.08 |
Dividend yield | 1.84% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
Monthly Dividends
The table displays the monthly dividend distributions for VanEck Vectors Pharmaceutical ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.41 | $0.00 | $1.30 | |
| 2023 | $0.00 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.34 | $0.00 | $0.31 | $1.70 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.27 | $0.00 | $0.24 | $1.20 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.35 | $0.00 | $0.27 | $1.25 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.27 | $1.10 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.29 | $0.00 | $0.17 | $1.14 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.24 | $0.00 | $0.20 | $1.08 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.22 | $0.00 | $0.15 | $1.14 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.22 | $0.00 | $0.15 | $1.27 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.20 | $1.26 |
| 2014 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.20 | $0.00 | $0.24 | $1.10 |
| 2013 | $0.04 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.21 | $0.00 | $0.18 | $1.08 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the VanEck Vectors Pharmaceutical ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VanEck Vectors Pharmaceutical ETF was 46.49%, occurring on Jul 23, 2002. Recovery took 2420 trading sessions.
The current VanEck Vectors Pharmaceutical ETF drawdown is 11.68%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -46.49% | Dec 29, 2000 | 389 | Jul 23, 2002 | 2420 | Mar 1, 2012 | 2809 |
| -30.17% | Aug 6, 2015 | 1165 | Mar 23, 2020 | 200 | Jan 6, 2021 | 1365 |
| -21.14% | Feb 9, 2000 | 19 | Mar 7, 2000 | 20 | Apr 4, 2000 | 39 |
| -20.26% | Apr 11, 2022 | 117 | Sep 27, 2022 | 216 | Aug 8, 2023 | 333 |
| -15.07% | Jul 12, 2000 | 40 | Sep 6, 2000 | 33 | Oct 23, 2000 | 73 |
Volatility
Volatility Chart
The current VanEck Vectors Pharmaceutical ETF volatility is 3.94%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.